<DOC>
	<DOCNO>NCT01434121</DOCNO>
	<brief_summary>The major goal project determine whether intravenously infuse ascorbic acid safe use viable therapeutic strategy adult human sepsis .</brief_summary>
	<brief_title>Ascorbic Acid ( Vitamin C ) Infusion Human Sepsis</brief_title>
	<detailed_description>Evolving data experimental animal strongly suggest ascorbic acid potently interrupt multiple biological process lead organ injury follow onset sepsis . Data present suggests ascorbic acid potently attenuate lung injury produce septic insult . Sepsis septic shock secondary bacterial fungal blood stream infection lead cause death critically ill patient . At present , 28 day mortality septic patient average 40 % best ICUs . In sepsis , disseminate intravascular coagulation produce widespread systemic microvascular thrombosis lead multiple organ injury ( i.e. , lung , liver , kidney , intestinal , cardiovascular ) . Despite aggressive intravascular volume resuscitation vasopressor support , appropriate antibiotic administration , expert critical care management , mortality remain high . Only single agent approve disrupt progressive sepsis-associated microvascular thrombosis ( activate protein C , [ Drodrecogin Alpha , brand name : Xigris , Lilly ] ) . No non-antibiotic pharmaceutical agent currently approve use sepsis . Activated protein C ( APC ) continuous infusion protocol span 96 hour period . APC infusion produce significant anticoagulation , therefore major risk use hemorrhage . Thus , recent surgery , especially neurosurgical procedure , major contraindication APC use . Finally , cost stand important issue APC use . A 96 hour APC infusion 70 kg patient VCUHS cost patient $ 33,000 ( source VCUHS Pharmacy Services ) . Use APC sepsis remain controversial fail achieve widespread acceptance . The goal current study determine safety ascorbic acid infusion septic human .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>1. systemic inflammatory response : fever ( 38°C great ) hypothermia ( 36°C low ) , tachypnea ( 20 breaths/min ) need mechanical ventilation acute process , tachycardia ( rate 90/min ) , white blood cell count ≥ 12,000 cells/mm3 ≤ 4,000 cells/mm3 10 % band form . 2 . Presumed Known Site Infection : Purulent sputum , chest radiograph new infiltrate , spillage bowel content , radiographic physical examination evidence infect collection , white blood cell normally sterile body fluid , positive blood culture , evidence infect mechanical hardware physical , radiographic , ultrasonographic evidence . 3 . Evidence Dysfunction One More End Organs : cardiovascular dysfunction : mean arterial pressure 60 mm Hg le , need vasopressor maintain pressure presence adequate intravascular volume ( central venous pressure 12 mmHg ) ; respiratory failure : ( arterial PO2toFiO2 ratio le 250 less 200 presence pneumonia ; renal dysfunction : Urine output ≤ 0.5 ml/kg/hr 2 hour presence adequate intravascular volume double serum creatinine ; hematologic dysfunction : thrombocytopenia ≤ 80,000 platelets/mm3 50 % decrease baseline acute illness ; Unexplained metabolic acidosis : arterial pH ≤ 7.3 plasma lactate level high 2.5 . Hepatic Dysfunction : Acute Serum transaminase elevation great five time normal . 4 . Informed Consent : Ability obtain informed consent within 48 hour . 1 . Demographic Characteristics : Children ( age &lt; 18 year ) , pregnant woman , prisoner , ward state exclude participation study . 2 . Informed Consent : Inability obtain informed consent within 48 hour . 3 . Cognitive Impairment : In absence family next kin , investigator feel patient cognitively impaired , unable provide inform consent , patient access study . 4 . NonEnglish Speaking Patients : Patients non english speaking access study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>